[The effect of Bactrim and Tandearil on abnormal tubal patency in cases of infertility (author's transl)]

other public-domain-us
View on PubMed

Abstract

In 257 patients with primary or secondary infertility, tubal occlusion or impeded tubal patency was found. The patients received Bactrim or Tandearil and the tubal patency was retested. In a control group of 74 cases, 2 tubal patency tests were done without treatment. Following treatment with Bactrim, 40,4% of the previously occluded fallopian tubes were patent. Following treatment with Tandearil, 34% of the previously occluded tubes were patient. In the non-treated group, 25% of the cases showed tubal patency at the second patency test. The results were more striking for the cases with impeded tubal patency. The success rate was 73,3% following treatment with Bactrim, 50% following treatment with Tandearil and 26,7% in the untreated control group.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Infertility, Female Oxyphenbutazone Sulfamethoxazole Trimethoprim Drug Combinations Endometriosis Endometriosis Exanthema Exanthema Fallopian Tube Patency Tests Female Humans Infertility, Female Infertility, Female Oxyphenbutazone Oxyphenbutazone Pressure Salpingitis Salpingitis Sulfamethoxazole

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-02T06:10:09.037253+00:00
pubmed
last seen: 2026-05-14T05:59:03.573854+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine